Small Heat Shock Proteins and Doxorubicin-Induced Oxidative Stress in the Heart

作者: Karthikeyan Krishnamurthy , Ragu Kanagasabai , Lawrence J. Druhan , Govindasamy Ilangovan

DOI: 10.1007/978-1-60761-956-7_5

关键词:

摘要: Doxorubicin (Dox) and its derivatives are used as chemotherapeutics, either alone or in combination with other agents. Dilated cardiomyopathy congestive heart failure due to cardiotoxicity continues be the most serious side effect, imposing severe limitations use of these agents despite arrival new classes Dox-derivatives formulations. In this chapter we summarize recent understanding mechanism Dox-induced relevance stress-inducible proteins, special emphasis on small heat shock proteins such Hsp27, Hsp20, etc. The expressed a response oxidative stress redox reactions drugs generation reactive oxygen species (ROS). On hand, ROS also known induce various MAP kinases phosphorylate activate stress-responding transcription factors, including factors (HSF). Activation HSF-1 leads induction series depending upon type exerted stress. Recent studies have confirmed that indeed activation especially Hsps heart. been found involved cell signaling can cardioprotective detrimental. Additionally, few transgenic animal models shown selective overexpression against Dox. These results establish fact proper regulation function could eliminate serve potential therapeutic target protect from toxicity.

参考文章(145)
Catherine Rice-Evans, Nicholas J. Miller, TOTAL ANTIOXIDANT STATUS IN PLASMA AND BODY FLUIDS Methods in Enzymology. ,vol. 234, pp. 279- 293 ,(1994) , 10.1016/0076-6879(94)34095-1
André-Patrick Arrigo, Catherine Paul, Cécile Ducasse, Olivier Sauvageot, Carole Kretz-Remy, Small Stress Proteins: Modulation of Intracellular Redox State and Protection Against Oxidative Stress Small Stress Proteins. ,vol. 28, pp. 171- 184 ,(2002) , 10.1007/978-3-642-56348-5_9
R Mestril, W H Dillmann, Heat shock proteins in myocardial stress. Zeitschrift Fur Kardiologie. ,vol. 84, pp. 87- 90 ,(1995)
Stephen Epstein, Charles Myers, Charles Myers, Charles Myers, Brian Corden, Brian Corden, Brian Corden, Sebastian Palmeri, Sebastian Palmeri, Sebastian Palmeri, James Doroshow, James Doroshow, James Doroshow, Robert Bonow, Gershon Locker, Gershon Locker, Gershon Locker, Jean Jenkins, Jean Jenkins, Jean Jenkins, Stephen Epstein, Stephen Epstein, A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine. Seminars in Oncology. ,vol. 10, pp. 53- 55 ,(1983)
G. Li, Y. Chen, J. T. Saari, Y. J. Kang, Catalase-overexpressing transgenic mouse heart is resistant to ischemia-reperfusion injury American Journal of Physiology-heart and Circulatory Physiology. ,vol. 273, ,(1997) , 10.1152/AJPHEART.1997.273.3.H1090
U F Rasmussen, H N Rasmussen, The NADH oxidase system (external) of muscle mitochondria and its role in the oxidation of cytoplasmic NADH. Biochemical Journal. ,vol. 229, pp. 631- 641 ,(1985) , 10.1042/BJ2290631
Peter Carson, Inder Anand, Christopher O’Connor, Brian Jaski, Jonathan Steinberg, Amy Lwin, JoAnn Lindenfeld, Jalil Ghali, Jodi H. Barnet, Arthur M. Feldman, Michael R. Bristow, Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial. Journal of the American College of Cardiology. ,vol. 46, pp. 2329- 2334 ,(2005) , 10.1016/J.JACC.2005.09.016
Alvaro Mordente, Maria Elisabetta Clementi, Francesco Misiti, Bruno Giardina, Enrico Di Stasio, Doxorubicin-derived metabolites induce release of cytochrome C and inhibition of respiration on cardiac isolated mitochondria. Anticancer Research. ,vol. 23, pp. 2445- 2450 ,(2003)
L. Rossini, E. Monti, D. Cova, F. Piccinini, Determination of Doxorubicin and Doxorubicin-3-ol in Rat Heart Archives of Toxicology. ,vol. 9, pp. 474- 478 ,(1986) , 10.1007/978-3-642-71248-7_102